本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LifeStance Health Group, Inc.

12.78
-0.6000-4.48%
成交量:181.52萬
成交額:2,341.86萬
市值:48.83億
市盈率:99.19
高:13.34
開:13.32
低:12.71
收:13.38
52周最高:13.56
52周最低:4.77
股本:3.82億
流通股本:2.57億
量比:0.38
換手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):0.1288
每股收益(LYR):0.0200
淨資產收益率:3.43%
總資產收益率:2.32%
市淨率:3.31
市盈率(LYR):639.00

資料載入中...

2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/11

重要事件披露

Form 8-K - Current report
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities